L
ADING

Altis Biosystems

Altis Biosystems

Best Early-Stage Biotech Compa & GHP Innovation Award in Cell-Based Drug Testing 2019ny - USA

Altis Biosystems has developed a patent-pending stem cell technology that recreates the human intestinal epithelium in a high-throughput format, using proliferative stem cells and terminally differentiated cells, for compound screening and microbiome research. Altis’ market is to assist pharmaceutical and biotechnology companies in reducing the cost and time of drug discovery by providing a platform that more closely replicates the human body’s native biology. This should also reduce the need for animal testing. Altis provides its platform the contract research services and by selling it as a kit for testing in customer facilities.